PacBio to Present at Upcoming Investor Conferences
PacBio (NASDAQ: PACB), a developer of high-quality sequencing solutions, has announced its participation in two upcoming investor conferences. Management will present at the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, at 2:30 PM ET in Boston, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, 2025, at 12:20 PM ET in New York.
Investors can access live webcasts of both presentations through PacBio's investor relations website, with replays available for at least 30 days after each event.
PacBio (NASDAQ: PACB), sviluppatore di soluzioni di sequenziamento di alta qualità, ha annunciato la sua partecipazione a due prossime conferenze per investitori. Il management presenterà al Canaccord Genuity 45th Annual Growth Conference il 12 agosto 2025 alle 14:30 ET a Boston, e al Morgan Stanley 23rd Annual Global Healthcare Conference il 10 settembre 2025 alle 12:20 ET a New York.
Gli investitori potranno seguire le dirette web di entrambe le presentazioni tramite il sito web delle relazioni con gli investitori di PacBio, con le registrazioni disponibili per almeno 30 giorni dopo ogni evento.
PacBio (NASDAQ: PACB), desarrollador de soluciones de secuenciación de alta calidad, ha anunciado su participación en dos próximas conferencias para inversores. La dirección presentará en la Canaccord Genuity 45th Annual Growth Conference el 12 de agosto de 2025 a las 2:30 PM ET en Boston, y en la Morgan Stanley 23rd Annual Global Healthcare Conference el 10 de septiembre de 2025 a las 12:20 PM ET en Nueva York.
Los inversores podrán acceder a las retransmisiones en vivo de ambas presentaciones a través del sitio web de relaciones con inversores de PacBio, con repeticiones disponibles durante al menos 30 días después de cada evento.
PacBio (NASDAQ: PACB)는 고품질 시퀀싱 솔루션 개발업체로서, 다가오는 두 개의 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 경영진은 2025년 8월 12일 오후 2시 30분(동부시간) 보스턴에서 열리는 Canaccord Genuity 45th Annual Growth Conference와 2025년 9월 10일 오후 12시 20분(동부시간) 뉴욕에서 열리는 Morgan Stanley 23rd Annual Global Healthcare Conference에서 발표할 예정입니다.
투자자들은 PacBio 투자자 관계 웹사이트를 통해 두 발표 모두의 생중계에 접속할 수 있으며, 각 행사 후 최소 30일 동안 다시보기 서비스를 이용할 수 있습니다.
PacBio (NASDAQ : PACB), développeur de solutions de séquençage de haute qualité, a annoncé sa participation à deux prochaines conférences pour investisseurs. La direction présentera lors de la Canaccord Genuity 45th Annual Growth Conference le 12 août 2025 à 14h30 ET à Boston, ainsi que lors de la Morgan Stanley 23rd Annual Global Healthcare Conference le 10 septembre 2025 à 12h20 ET à New York.
Les investisseurs pourront accéder aux webdiffusions en direct des deux présentations via le site des relations investisseurs de PacBio, avec des rediffusions disponibles pendant au moins 30 jours après chaque événement.
PacBio (NASDAQ: PACB), ein Entwickler hochwertiger Sequenzierungslösungen, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Management wird auf der Canaccord Genuity 45th Annual Growth Conference am 12. August 2025 um 14:30 Uhr ET in Boston und auf der Morgan Stanley 23rd Annual Global Healthcare Conference am 10. September 2025 um 12:20 Uhr ET in New York präsentieren.
Investoren können beide Präsentationen live über die Investor-Relations-Website von PacBio verfolgen, wobei Wiederholungen für mindestens 30 Tage nach jeder Veranstaltung verfügbar sind.
- None.
- None.
MENLO PARK, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:
- Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 2:30 PM ET in Boston, MA
- Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025, at 12:20 PM ET in New York, NY
Live webcasts of the events can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcasts will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
FAQ
When is PacBio (PACB) presenting at the Canaccord Genuity Growth Conference 2025?
When is PacBio's presentation at the Morgan Stanley Healthcare Conference 2025?
How can investors access PacBio's (PACB) conference presentations?
Which investor conferences is PacBio (PACB) attending in 2025?
